Literature DB >> 8764087

Properties of the novel herpes simplex virus type 1 origin binding protein, OBPC.

K Baradaran1, M A Hardwicke, C E Dabrowski, P A Schaffer.   

Abstract

We have recently identified a novel 53-kDa herpes simplex virus type 1 (HSV-1) protein encoded by, and in frame with, the 3' half of the UL9 open reading frame, designated OBPC (K. Baradaran, C. Dabrowski and P. A. Schaffer, J. Virol. 68:4251-4261, 1994). Here we show that OBPC is a nuclear protein synthesized at both early and late times postinfection. In gel-shift assays in vitro-synthesized OBPC bound to oriS site I DNA to form a complex identical in mobility to complex A, generated with infected cell extracts and site I DNA. OBPC inhibited both plaque formation and viral DNA replication in transient assays, consistent with its ability to bind to site I DNA and its limited ability to interact with other essential DNA replication proteins. These properties suggest that OBPC may play a role in the initiation, elongation, or packaging of viral DNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764087      PMCID: PMC190533     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Analysis of Ori-S sequence of HSV-1: identification of one functional DNA binding domain.

Authors:  S Deb; S P Deb
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

2.  Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein.

Authors:  P D Olivo; N J Nelson; M D Challberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Identification of the site of interruption in relaxed circles producing during bacteriophage lambda DNA circle replication.

Authors:  R C Reuben; A Skalka
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

4.  The circle mode of replication of bacteriophage lambda: the role of covalently closed templates and the formation of mixed catenated dimers.

Authors:  J M Sogo; M Greenstein; A Skalka
Journal:  J Mol Biol       Date:  1976-05-25       Impact factor: 5.469

5.  Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication.

Authors:  H M Weir; J M Calder; N D Stow
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

6.  Herpes simplex virus type 1 gene products required for DNA replication: identification and overexpression.

Authors:  P D Olivo; N J Nelson; M D Challberg
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome.

Authors:  R Heilbronn; H zur Hausen
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Cloning and characterization of herpes simplex virus type 1 oriL: comparison of replication and protein-DNA complex formation by oriL and oriS.

Authors:  M A Hardwicke; P A Schaffer
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Studies on the replication of Escherichia coli phage lambda DNA. I. The kinetics of DNA replication and requirements for the generation of rolling circles.

Authors:  M Better; D Freifelder
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

10.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  11 in total

1.  Origin binding protein-containing protein-DNA complex formation at herpes simplex virus type 1 oriS: role in oriS-dependent DNA replication.

Authors:  J A Isler; P A Schaffer
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  DNA binding activity of the herpes simplex virus type 1 origin binding protein, UL9, can be modulated by sequences in the N terminus: correlation between transdominance and DNA binding.

Authors:  Soma Chattopadhyay; Sandra K Weller
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Cellular transcription factors enhance herpes simplex virus type 1 oriS-dependent DNA replication.

Authors:  A T Nguyen-Huynh; P A Schaffer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

6.  Functional characterization of Marek's disease virus (MDV) origin-binding protein (OBP): analysis of its origin-binding properties.

Authors:  T F Wu; H H Chen; H Wu
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

7.  Phosphorylation of the herpes simplex virus type 1 origin binding protein.

Authors:  J A Isler; P A Schaffer
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells.

Authors:  M A Hardwicke; P A Schaffer
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Existence of transdominant and potentiating mutants of UL9, the herpes simplex virus type 1 origin-binding protein, suggests that levels of UL9 protein may be regulated during infection.

Authors:  Boriana Marintcheva; Sandra K Weller
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Cathepsin B mediates cleavage of herpes simplex virus type 1 origin binding protein (OBP) to yield OBPC-1, and cleavage is dependent upon viral DNA replication.

Authors:  Malen A Link; Laurie A Silva; Priscilla A Schaffer
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.